Literature DB >> 20646761

Occurrences of opportunistic infections in chronic myelogenous leukemia patients treated with imatinib mesylate.

Navin Anthony1, James Shanks, Howard Terebelo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20646761     DOI: 10.1016/j.leukres.2010.05.019

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.

Authors:  Joshua S Davis; David Ferreira; Emma Paige; Craig Gedye; Michael Boyle
Journal:  Clin Microbiol Rev       Date:  2020-06-10       Impact factor: 26.132

Review 2.  Infections in patients on BCR-ABL tyrosine kinase inhibitor therapy: cases and review of the literature.

Authors:  Bettina M Knoll; K Seiter
Journal:  Infection       Date:  2018-01-31       Impact factor: 3.553

3.  Low incidence rate of opportunistic and viral infections during imatinib treatment in chronic myeloid leukemia patients in early and late chronic phase.

Authors:  Massimo Breccia; Corrado Girmenia; Roberto Latagliata; Giuseppina Loglisci; Michelina Santopietro; Vincenzo Federico; Luigi Petrucci; Alessandra Serrao; Adriano Salaroli; Giuliana Alimena
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-16       Impact factor: 2.576

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.